Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arsenic activated GLUT1-mTORC1/HIF-1α-PKM2 positive feedback networks promote proliferation and migration of bladder epithelial cells. | Sci Total Environ | 2024 | 38977090 | PubTator, text mining | PubMed |
| Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma. | Front Pharmacol | 2024 | 38974045 | PubTator, text mining | PubMed |
| [Identification of the binding proteins of organic acid metabolites by matrix thermal shift assay]. | Se Pu | 2024 | 38966978 | PubTator, text mining | PubMed |
| Hypoxia in uterine fibroids: role in pathobiology and therapeutic opportunities. | Oxygen (Basel) | 2024 | 38957794 | PubTator, text mining | PubMed |
| NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ Depletion. | Mol Cancer Res | 2024 | 38949523 | PubTator, text mining | PubMed |
| Case report: A healthy baby achieved after preimplantation genetic testing from an infertile woman with hereditary leiomyomatosis and renal cell cancer syndrome. | Front Med (Lausanne) | 2024 | 38933105 | PubTator, text mining | PubMed |
| Intravascular Laser Blood Irradiation (ILIB) Enhances Antioxidant Activity and Energy Metabolism in Aging Ovaries. | J Pers Med | 2024 | 38929772 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Revealed a Pathogenic Germline Variant in the Fumarate Hydratase Gene, Leading to the Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer. | Diagnostics (Basel) | 2024 | 38928693 | PubTator, text mining | PubMed |
| Failed Induction of the TH1 System in TH2 Dominant Patients: The Cancer-Permissive Immune Macroenvironment. | Integr Med (Encinitas) | 2024 | 38911450 | PubTator, text mining | PubMed |
| A 23-year bibliometric analysis of the development of global research on hereditary renal carcinoma. | Front Oncol | 2024 | 38887238 | PubTator, text mining | PubMed |
| Functional implications of fumarate-induced cysteine succination. | Trends Biochem Sci | 2024 | 38876954 | PubTator, text mining | PubMed |
| Quadruple Primary Malignancies over 2 Years with Germline Mutation in Krebs Cycle Enzyme Gene Fumarate Hydratase. | Case Rep Genet | 2024 | 38873645 | PubTator, text mining | PubMed |
| Privileged proteins with a second residence: dual targeting and conditional re-routing of mitochondrial proteins. | FEBS J | 2024 | 38857249 | PubTator, text mining | PubMed |
| Uterine Leiomyomas with Specific Histology Features of Two Fumarate Hydratase/Succinate Dehydrogenase-Deficient Tumors: A Double Case Report. | Medicina (Kaunas) | 2024 | 38793008 | PubTator, text mining | PubMed |
| Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer. | Int J Mol Sci | 2024 | 38791507 | PubTator, text mining | PubMed |
| Case report: Uterine leiomyoma with fumarate hydratase deficiency. | Front Med (Lausanne) | 2024 | 38784227 | PubTator, text mining | PubMed |
| The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates. | Cureus | 2024 | 38765391 | PubTator, text mining | PubMed |
| [2022 WHO classification of renal cell carcinomas: Focus on papillary renal cell carcinoma]. | Ann Pathol | 2024 | 38729793 | PubTator, text mining | PubMed |
| Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase (FH) as pathogenic. | Genes Chromosomes Cancer | 2024 | 38682608 | PubTator, text mining | PubMed |
| Presenting metabolomics analyses: what's in a number? | EMBO J | 2024 | 38664540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=8